强生公司提出支付55亿美元以解决剩余的滑石粉相关诉讼[1]。这些诉讼声称该公司的滑石粉产品导致卵巢癌[1]。根据该和解提议，至少需要95%的剩余索赔人参与才能生效[1]。
根据付款安排，初始支付不超过30亿美元将在明年进行，此后无追加支付义务直至2028年[1]。这一提议旨在终结强生超过十年的滑石粉法律纠纷[1]。此前，美国破产法院法官去年驳回了强生子公司Red River Talc提议的90亿美元和解方案[1]。强生此前已解决约95%的石棉肺癌诉讼和所有州消费者保护索赔[1]。消息公布后，强生股价在周二开盘前上涨超过2%[1]。
Johnson & Johnson has proposed a $5.5 billion settlement to resolve the remaining talc-related lawsuits against the company, which allege that its talc products caused ovarian cancer.[1] The settlement requires approval from at least 95% of the remaining claimants, with an initial payment not exceeding $3 billion to be made next year.[1] No additional payments would be required until 2028.[1]
The proposal marks the company's latest attempt to end litigation that has persisted for over a decade.[1] A federal bankruptcy judge rejected a previous $9 billion settlement plan proposed by the company's subsidiary Red River Talc last year.[1] Johnson & Johnson has already resolved approximately 95% of asbestos-related lung cancer lawsuits and all state consumer protection claims.[1] The announcement boosted the company's stock price, which rose more than 2% ahead of Tuesday's market opening.[1]